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Abstract. The X-ray induction of tumors was examined in
five-week-old male Otsuka Long-Evans Tokushima Fatty
(OLETF) rats, treated with two 10 Gy doses to the gastric
region with a 3-day interval (total 20 Gy). After irradiation,
the rats received the commercial diet MF and tap water and
were maintained for up to 564 days. The mean serum glucose
level in the X-irradiated group was significantly lower than
that in the non-irradiated animals at the 18 month time point.
The total tumor incidence was 27/30 (87.1%) in the treated rats
(islet tumors, gastric tumors, sarcomas, seminomas, adrenal
tumors, kidney tumors, papilloma, lymphomas and mammary
tumors). Islet tumors, generally showed to be positive for
insulin by immunohistochemistry, developed in 19 rats
(63.3%), and were associated with low serum glucose. Since
spontaneous tumors observed in 6/19 (31.6%) rats (sarcomas,
kidney tumors, duodenum tumors, seminoma, adrenal tumor
and squamous cell carcinoma) did not include any insulinomas,
these are clearly induced by X-irradiation in OLETF rats.
Introduction
Insulinoma, arising from the ß-islet cells in the Langerhans
islets, is one of the most common endocrine tumors of the
pancreas with an annual incidence of 0.5 per million population
(1). Experimental models for insulinomas induced by X-
irradiation (2-4) or chemicals (5,6) have been reported and
we previously described the induction of pancreatic tumors
by local X-irradiation in Sprague-Dawley (SD) rats (7,8).
The Otsuka Long-Evans Tokushima Fatty (OLETF) rats were
developed as an animal model of type II diabetes with obesity
by Kawano et al (9) and exhibited a late onset of chronic and
slowly progressive hyperglycemia, with innate polyphagia
causing rapid body weight gain, hyperinsulinemia and
hyperglycemia. Insulin resistance appears at 12-24 weeks of
age, and overt diabetes develops at 20-30 weeks. At later
than 40 weeks the rats become hypoinsulinemic, and exhibit
defects in insulin secretion (9-11). Histologically, the OLETF
rats also show progressive fibrosis in the pancreas (9,12).
After 20 weeks, fibrosis and the enlargement of the islets
clustered in connective tissue become prominent. After 40
weeks, the islets are increasingly replaced by connective
tissues and by 70 weeks the pancreas is extremely atrophic
and replaced by fatty and connective tissue. The number and
size of the islets decreased significantly over time. Thus, the
genetically obese hyperglycemic OLETF rat has many
similarities with the human type II diabetes and its diabetic
syndrome is characterized by a high degree of insulin
resistance (13,14). In the present study, we examined its
susceptibility to the induction of insulinoma by X-irradiation.
Materials and methods
Animals. OLETF (52, five-week-old male) rats were obtained
from the Tokushima Research Institute, Otsuka Pharmaceutical
Co., Tokushima, Japan (courtesy of Dr K. Kawano). They
were housed in polycarbonate cages under constant conditions
of temperature (24±2˚C), relative humidity (55±10%) with a
12-h light/12-h dark cycle, according to the Guide for Care
and Use of Laboratory Animals established by Hiroshima
University, and fed an MF commercial diet (Oriental Yeast
Co. Ltd., Tokyo, Japan).
X-irradiation. Rats were anaesthetized with Nembutal, and
X-irradiated according to the method previously described
(7,8). A 0.6-cm lead cover, with a hole of 1.8 cm in diameter,
was positioned so that the hole lay over the gastric region.
Each animal was given two X-ray doses of 10 Gy each, with
a 3-day interval (total 20 Gy). Exposure factors were as
follows: 200 kVp, filter 0.5 Cu + 1.0 Al, a half-value layer of
1.18 mm Cu, at a dose rate of 90 R/min as measured with a
Radocon 555 dosimeter. The X-ray air dose (in R) was then
converted to the absorbed dose (in cGy) using a factor of
0.95 cGy/R.
Examination of animals. All animals were regularly observed
and the survivors sacrificed and autopsied when they became
moribund or at the end of the experiment after 564 days. All
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major organs and tissues were resected, fixed in 10% neutral
formalin and processed routinely to paraffin-embedded
sections stained with hematoxylin and eosin.
Immunohistochemistry. Pancreatic tumors were fixed in
formalin and then routinely processed for embedding in
paraffin, sectioned, dewaxed, and incubated for 30 min at room
temperature with rabbit anti-insulin antibodies (purchased
from Shandon-Lipshaw, Pittsburgh, PA, USA). The sections
were then sequentially incubated with a biotin-labeled
secondary antibody and treated for demonstration of the
binding sites.
Statistical analysis. The significance of differences in the
numerical data was evaluated using the Chi-square test,
Student's t-test and Cox proportional hazard model for
multiple comparisons using logarithmic transformation.
Results
Data for the change in body weights over time are shown in
Fig. 1. The values for the non-irradiated controls were
significantly greater than those in the irradiated animals from
1 month after irradiation until day 486.
Serum glucose values, 3 months after irradiation, did not
significantly differ between the groups, but after 18 months
the levels (127.6±35.7 mg/dl) in the X-irradiated group were
significantly lower than those in the non-irradiated controls
(230±115 mg/dl) (P<0.01, Table I).
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Table I. Blood glucose values.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
X-irradiated Non-treated
–––––––––––––––––––––––––––––––– ––––––––––––––––––––––––––––––––––––––––––––––
Group No. of animals Glucose (mg/dl) No. of animals Glucose (mg/dl) P-value
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
3 months 30 193.8±54.3a 19 189.6±22.90 0.280
12 months 27 218.7±73.9 17 191.2±20.30 0.040
18 months 13 127.6±35.7 15 229.9±115.4 0.002
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
aMean ± SD.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Figure 1. Body weights. •, X-irradiated; ‡, non-irradiated.
Table II. Body and organ weights (relative weights)a.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Group BW Heart Liver Kidney Testis Adrenal Spleen
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
X-irradiated 635.0±125.2b 2.39±0.64 20.33±4.77 3.77±0.72 2.71±0.77 0.09±0.05 1.58±1.03
(0.39±0.13)c (3.19±0.66) (0.60±0.15) (0.42±0.14) (0.01±0.01) (0.25±0.18)
Non-irradiated 657.3±108.4 2.01±0.22 22.33±3.30 3.89±0.78 2.76±1.04 0.08±0.02 2.20±1.96
(0.30±0.06) (3.36±0.52) (0.59±0.17) (0.43±0.16) (0.01±0.004) (0.35±0.33)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
aOrgan/body weight x 100. bMean ± SD. cSignificantly different from the non-irradiated value (P<0.01).
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Figure 2. The induction of tumors in OLETF rats by X-irradiation. •, X-
irradiated; ‡, non-irradiated.
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After irradiation (564 days) all surviving animals were
autopsied. The mean survival was not significantly influenced
by irradiation. The organ weights did not significantly vary
between the groups, although the heart relative weights in the
X-irradiated group were significantly greater than those in
the non-irradiated group (Table II). The first tumor appeared
149 days after X-irradiation, with a gradually increasing
incidence thereafter (Fig. 2). The final total tumor incidence
in the X-irradiated group (27/30, 87.1%) was significantly
greater than that in the non-irradiated group (6/19, 31.6%)
(P<0.01, Table III). The cumulative tumor incidence was also
significantly different between the X- and non-irradiated
groups (Fig. 3, P=0.015). Islet tumors of the pancreas (Fig. 3)
appeared in 19 X-irradiated animals (63.3%), sarcomas in 7
(23.3%) and gastric tumors in 5 (16.7%). Single examples of
mammary tumors, lymphomas, seminomas, adrenal tumors,
squamous cell carcinomas and papillomas were also noted. In
the non-irradiated group, three sarcomas, 2 kidney and
duodenum tumors, 1 seminoma, an adrenal tumor and a
squamous cell carcinoma were observed.
The pancreata of non-irradiated animals were extremely
atrophic and the numbers and sizes of the islets were reduced
(Fig. 4). The islets of the irradiated rats, in contrast, were
enlarged. Acinar cells were atrophic and degenerated and
replacements by adipocytes and cell infiltration were observed.
Immunohistochemistry showed the islet tumor cells to be
generally positive against insulin antiserum (Fig. 5).
Intestinal metaplasia with ALP activity on the histopatho-
logical examination was more frequent in the X-irradiated
than in the non-irradiated groups (Table IV).
Discussion
The present study showed that the OLETF rat is very
susceptible to the induction of pancreas islet tumors, putative
insulinomas positive for insulin staining and associated with
a decrease of serum glucose concentration, by X-irradiation to
the gastric region. We previously described islet tumors of the
pancreas in 18% of Crj rats receiving the same two 10 Gy
doses to the gastric region with a 3-day interval (total 20 Gy)
(7). Boschetti et al (3) reported an 11.4% incidence of islet
cell tumors in non-inbred Wistar rats treated with 430 rads of
total body X-irradiation while the same treatment resulted in
a 2.2% incidence in inbred Wistar Furth rats. Kido et al (8)
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Table III. The induction of tumors.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Mean Incidence No. of Islet Sarcomas Gastric Other
survival of tumors tumors per tumors (%) tumors tumors
(days) (%) animal (%) (%)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
X-irradiated 473.9±127.4a 27/30 (87.1)b 1.3±1.1b 19/30 (63.3)b 7/30 (23.3) 5/30 (16.7) Seminoma 2
No. per Adrenal 2
animal Kidney 1
1.5±0.7 Squamous cell
carcinoma 1
Size Papilloma 1
3.5±2.3 mm Lymphoma 1
Mammary 1
Non-irradiated 525.6±92.1 6/19 (31.6) 0.5±0.8 0 3/19 (15.7) 0 Kidney 2
Duodenum 2
Seminoma 1
Adrenal 1
Squamous cell
carcinoma 1
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
aMean ± SD. bSignificantly different from the non-irradiated value (P<0.01).
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Figure 3. The induction of islet tumors by X-irradiation in OLETF rats. •,
X-irradiated.
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Figure 4. The pancreas of a non-irradiated control rat, x100 HE staining.
Figure 5. Immunostaining of an islet tumor for insulin, x100.
Table IV. Intestinal metaplasia incidences and numbers.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Pylorus Fundus
––––––––––––––––––––––––––––––––––––––––– –––––––––––––––––––––––––––––––––––––
Group Alkaline A B C Total A B C Total
phosphatase
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
X-irradiated 78.6% 53.3% 100% 86.7% 100% 6.7% 53.3% 40.0% 53.30%
174.8±179.1a,c 1.3±1.4c 39.8±36.2c 8.9±11.1c 50.1±46.6c 0.1±0.3 6.4±9.0c 1.9±3.1b 8.3±10.6c
Non-treated 71.4% 0% 100% 7.1% 100% 0 0 0 0
15.2±16.00 0 4.7±5.00 0.1±0.30 4.8±4.90 0 0 0 0
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Alkaline phosphatase activity in gastric mucosa. A, goblet cells in gastric mucosa; B, intestinal crypts without Paneth cells and C, intestinal
crypts with Paneth cells. aMean ± SD. bSignificantly different from the non-irradiated value (P<0.05). cSignificantly different from the non-
irradiated value (P<0.01).
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
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performed a localized X-irradiation to the gastric region of
SD rats and induced a very high incidence of pancreatic
tumors (25/28, 89.3%), most of which showed positive
immunoreactivity for rat insulin and expressed insulin mRNA,
as confirmed by Northern blot analysis. They also reported
an inverse correlation between the serum insulin and glucose
level and concluded that the pancreatic tumors induced by X-
irradiation were functional insulinomas. In the present study,
there was no examination of serum insulin, but the pancreatic
tumors were anti-insulin antigen positive. In the aged OLETF
rats, the exocrine and endocrine pancreas is extremely
atrophic, and is replaced by fatty and connective tissues.
The number and size of the islets decreases significantly
(9,12,16-18) in line with the development of type II diabetes
(9). Therefore, by inducing insulinomas X-irradiation allowed
for the control of serum glucose levels to be maintained.
Gross and Dreyfuss reported a 10% incidence of
spontaneous tumors in male Long-Evans rats, the lesions
being fibromas, fibrosarcomas or leukemias and lymphomas
(15). Pituitary tumors (19-21), multiple endocrine neoplasia
syndrome (21), pancreatic tumors (21-23) and skin lesions
(24) have been reported in aging Long-Evans rats. The Long-
Evans Cinnamon rat, a mutant, features hepatitis and
spontaneous liver tumors (25,26). As with the Eker model,
Long-Evans rats typically develop multiple renal tumors (27).
Thus, there may be certain differences in the spontaneous
development of tumors between Long-Evans, substrain and
OLETF rats.
In conclusion, OLETF rats may provide a useful strain to
investigate insulinomas induced by X-ray irradiation.
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